4‐1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4‐1BB agonists is a research paper published in Cancer Communications (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5U01CA180888‐08
National Institutes of Health
Grant: 5UG1CA233198‐05
NIH HHS
Grant: 5UG1CA233198-05
MCW NCTN Lead Academic Participating Site
NCI NIH HHS
Grant: U10 CA180888
NCI NIH HHS
Grant: UG1 CA233198
NIH HHS
Grant: 5U01CA180888-08
National Institutes of Health
Grant: 3U10CA180888-03S1
SWOG Network Group Operations Center of the NCTN
FWCI
0.73
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords